EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Navigating the clinical landscape: Update on the diagnostic and prognostic biomarkers in multiple myeloma

Sahana Kabbathi Raghunathachar, Kiran Pura Krishnamurthy, Lokesh Maragowdanahalli Gopalaiah, D Abhijith, Akila Prashant, S R Parichay, Arpitha Maraliga Ramesh

Molecular Biology Reports · 2024

DOI: 10.1007/s11033-024-09892-w ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Sahana Kabbathi Raghunathachar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, JSS Medical College, JSS Academy of Higher Education & Research, Mysuru, 570015, India. Hauptthemen laut MEDLINE: Multiple Myeloma, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 107 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma, a complex hematologic malignancy, has devastating consequences for patients, including dramatic bone loss, severe bone pain, and pathological fractures that markedly decrease the quality of life and impact the survival of affected patients. This necessitates a refined understanding of biomarkers for accurate diagnosis and prognosis of such severe malignancy. Therefore, this article comprehensively covers current research, elucidating the diverse spectrum of biomarkers employed in clinical settings. From traditional serum markers to advanced molecular profiling techniques, the review provides a thorough examination of their utility and limitations. Through this scoping review, emphasis is placed on the evolving landscape of personalized medicine, where biomarkers play a pivotal role in tailoring therapeutic strategies. The integration of genomic, proteomic, next generation sequencing and flow cytometric data further enriches the discussion, unravelling the molecular intricacies underlying disease progression. The updated criteria allow for the treatment of people who clearly would benefit from therapy and might live longer if treated before significant organ damage occurs. Navigating through the evolving diagnostic and prognostic paradigms in multiple myeloma, this article equips clinicians and researchers with crucial insights for optimizing patient care and advancing future therapeutic approaches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaBiomarkers, TumorHumansPrognosisPrecision MedicineProteomicsHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

BiomarkersHaematologic malignancyMolecular profilingPatient carePersonalized medicine

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Biochemistry, JSS Medical College, JSS Academy of Higher Education & Research, Mysuru, 570015, India.
  • Department of Oncology, JSS Medical College, JSS Academy of Higher Education & Research, Mysuru, 570015, India.
  • Mysore Medical College and Research Institute, Mysuru, 570015, India.
  • Medgenome labs, Bengaluru, 560100, India.
  • Department of Biochemistry, JSS Medical College, JSS Academy of Higher Education & Research, Mysuru, 570015, India. arpithamr@jssuni.edu.in.

Zitieren

APA

Raghunathachar, S. K., Krishnamurthy, K. P., Gopalaiah, L. M., Abhijith, D., Prashant, A., Parichay, S. R., & Ramesh, A. M. (2024). Navigating the clinical landscape: Update on the diagnostic and prognostic biomarkers in multiple myeloma. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09892-w

Vancouver

Raghunathachar SK, Krishnamurthy KP, Gopalaiah LM, Abhijith D, Prashant A, Parichay SR, et al. Navigating the clinical landscape: Update on the diagnostic and prognostic biomarkers in multiple myeloma. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09892-w

BibTeX
@article{Raghunathachar2024,
  author = {Raghunathachar, Sahana Kabbathi and Krishnamurthy, Kiran Pura and Gopalaiah, Lokesh Maragowdanahalli and Abhijith, D and Prashant, Akila and Parichay, S R and Ramesh, Arpitha Maraliga},
  title = {Navigating the clinical landscape: Update on the diagnostic and prognostic biomarkers in multiple myeloma},
  journal = {Molecular Biology Reports},
  year = {2024},
  doi = {10.1007/s11033-024-09892-w}
}
Kostenlos starten →